The Effect of Supplementation With Fish Oil (EPAX EVOLVE 05) on Sperm Quality

NCT06950203 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-05-01

No results posted yet for this study

Summary

The study will enrol men that have a poor sperm quality. They will take either a placebo or fish oil capsule (2 per day) for 3 months. At the beginning and end of the study the participant will be asked for a sperm sample for measuring quality parameters.

Conditions

  • Infertility, Male

Interventions

DIETARY_SUPPLEMENT

Very Long Chain Polyunsaturated Fatty Acids

Fish oil with DHA and VLCPUFA

DIETARY_SUPPLEMENT

Comparator arm (DHA)

Oil containing equal DHA content to active arm

Sponsors & Collaborators

  • Epax Norway AS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-10
Primary Completion
2026-09-01
Completion
2026-12-20

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06950203 on ClinicalTrials.gov